Baxter/Nexell
This article was originally published in The Gray Sheet
Executive Summary
Firms ink definitive agreement for Baxter to distribute Nexell cell processing products, including the Isolex 300i magnetic cell selection system, worldwide. A letter of intent was announced in June (1"The Gray Sheet" June 18, 2001, p. 15). As part of the deal, Baxter will acquire certain assets and liabilities of the business for an estimated $4.3 mil. and will pay royalties on future sales. Closing is expected by Oct. 1